FY25 Appendix 4E & Annual Report
Filed with ASX · · 48 pages · English
Summary by 6ix AI
The report indicates a substantial reduction in net loss after tax compared to the previous year, alongside a notable gain from a Deed of Company Arrangement. The company underwent voluntary administration and sold its main business operations during the year, transitioning to a corporate office focused on recapitalization and investment opportunities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Genetic Technologies Limited on 6ix
Story so far
Earlier from Genetic Technologies
- Suspension from Official Quotation - Annual Listing Fees
- Quarterly Activities/Appendix 4C Cash Flow Report Sept 2025
- Quarterly Activities/Appendix 4C Cash Flow Report June 2025
- Quarterly Activities/Appendix 4C Cash Flow Report March 2025
- Update on Proposed Acquisition Strategy
Later from Genetic Technologies
- Quarterly Activities/Appendix 4C Cash Flow Report June 2026
- FY26 Annual Report
- Long Term Suspended Entities
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies